If your that unsure that you need a new ceo and to be talked into selling shares you may or may not have. Don’t let the door hit you, sorry have had enough of the soft bashing. If you like a restaurant for the prices and atmosphere so you keep going in because sometimes the food is great but you hate the chef that is working most nights you go in even though a lot of others love the taste of his cooking but you think it’s horrible. This particular chef is part owner he rescued the restaurant when it didn’t have any funds and about to go bankrupt but he rescued the restaurant built it up t what it is, so it doesn’t really matter what you think of the chef or that you like some things about the restaurant but not the chef. The chef in this restaurant is Nadar some like him some don’t but he is the chef and constantly complaining about him is not going to change CEO’s and pipe-dream of big pharma is to buy out CYDY on the cheap this chef will not let that happen that’s the real reason they don’t like him. Blame the DSMC blame the FDA blame the scientific board, lots of blame of why such a promising drug has to do additional 140 patients is because the FDA is playing obvious big pharma favorites. CYDY is not playing on a fair field they have already embarrassed the top drugs of all bog pharma combined in CD-10 trial and CD-12. Big pharma has bought more time to sell their crap but they can’t hold back CYDY much longer and they know it.